Karsten Spiekermann

Munich, BY 81377, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 189 publications

Recognizing, classifying, and treating thrombocytopenia

Recognizing, classifying, and treating thrombocytopenia

Journal: MMW Fortschritte der Medizin

Published: March 20, 2026

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

Journal: The New England journal of medicine

Published: March 04, 2026

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.

Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.

Journal: Nature medicine

Published: January 07, 2026

AI-based hematological malignancy prediction from peripheral blood smears in a large diagnostic laboratory cohort.

AI-based hematological malignancy prediction from peripheral blood smears in a large diagnostic laboratory cohort.

Journal: Leukemia

Published: December 29, 2025

Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.

Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 23, 2025

Correction: Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxis.

Correction: Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxis.

Journal: Infection

Published: December 22, 2025

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

Journal: Leukemia

Published: December 10, 2025

Increasing TET Expression and 5-Hydroxymethylcytosine Formation by a Carbocyclic 5-Aza-2'-deoxy-cytidine Antimetabolite.

Increasing TET Expression and 5-Hydroxymethylcytosine Formation by a Carbocyclic 5-Aza-2'-deoxy-cytidine Antimetabolite.

Journal: Angewandte Chemie (International ed. in English)

Published: November 26, 2025

Seasonal community-acquired respiratory virus infections in patients with cancer-Epidemiological and clinical overview, an analysis of the multicenter OncoReVir registry.

Seasonal community-acquired respiratory virus infections in patients with cancer-Epidemiological and clinical overview, an analysis of the multicenter OncoReVir registry.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 24, 2025

Catheter-related complications in AML remission induction chemotherapy: a retrospective comparison of PICCs and CICCs.

Catheter-related complications in AML remission induction chemotherapy: a retrospective comparison of PICCs and CICCs.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: November 08, 2025

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO).

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO).

Journal: Annals of hematology

Published: October 24, 2025

Showing 1-12 of 189

Last Updated: 09/26/2026